HCM
DXCM icon

Highbridge Capital Management’s DexCom DXCM Stock Holding History

Highbridge Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-24,800
Closed -$355K – 1308
2017
Q4 		$355K Buy
+24,800
New +$322K 0.01% 1128
2017
Q2 		– Sell
-18,000
Closed -$381K – 1332
2017
Q1 		$381K Buy
+18,000
New +$351K 0.01% 1028

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Highbridge Capital Management's DXCM Position: Q3 2018 in Review

Highbridge Capital Management sold out of DexCom (DXCM) in Q3 2018, closing a stake of 443,312 shares — an estimated $10.5M sold.

Highbridge Capital Management first reported a position in DXCM in Q4 2016 and held it in 2 quarters. The position peaked at $10.5M in Q2 2018. 364 funds tracked by Wall St. Rank hold DXCM as of Q3 2018.

  • Highbridge Capital Management reported no remaining DexCom position as of Q3 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 443,312 DexCom shares in Q3 2018, an estimated $10.5M.
  • Highbridge Capital Management first reported a position in DexCom in Q4 2016 and held it in 2 quarters.
  • Highbridge Capital Management's DexCom position peaked at $10.5M in Q2 2018.
  • 364 funds tracked by Wall St. Rank held DexCom as of Q3 2018.

Based on Highbridge Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.